We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6269:TSEModec, Inc. Analysis

Data as of 2026-05-20 - not real-time

NT$58.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Flexium Interconnect is trading at TWD 58, notably below its 20‑day (TWD 62.7), 50‑day (TWD 61.2) and 200‑day (TWD 60.98) simple moving averages, indicating short‑term weakness. The RSI of 42.6 sits under the neutral 50 level and the MACD is in a bearish configuration, while volume is on a decreasing trend, suggesting limited buying pressure. On the valuation side, the forward P/E of 238× dwarfs the industry average of 38× and the discounted cash‑flow fair value of TWD 33.2 is far below the current price, flagging the stock as potentially overvalued despite a modest price‑to‑book of 0.87 and price‑to‑sales of 0.82.
Fundamentally, the company posted a 5.7% revenue increase but margins remain razor‑thin (gross margin 0.85%, operating margin -18%) and earnings are negative (trailing EPS -6.95). Debt is high with a debt‑to‑equity ratio of 17.0, while free cash flow is modestly positive, hinting at some liquidity cushion. Volatility is elevated at ~51% over 30 days, yet beta is low (0.36), and the stock faces medium‑to‑high geographic risk given Taiwan’s exposure to regional tensions. Overall, the blend of technical weakness, overvaluation on earnings, and fragile profitability suggests a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below all major SMAs and bearish MACD
  • Decreasing volume and neutral RSI
  • Support level near TWD 54.8 offering limited downside cushion

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Modest revenue growth (5.7%) but persistently negative margins
  • Low price‑to‑book and price‑to‑sales ratios suggesting some value
  • High debt‑to‑equity ratio (17) constraining financial flexibility

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Extreme forward P/E (238×) relative to industry peers
  • DCF fair value (TWD 33.2) far below current market price
  • Elevated volatility (≈51%) and ongoing profitability challenges

Key Metrics & Analysis

Financial Health

Revenue Growth5.70%
Profit Margin-11.00%
P/E Ratio238.1
ROE-10.36%
ROA-5.96%
Debt/Equity17.04
P/B Ratio0.9
Op. Cash FlowNT$-713635968
Free Cash FlowNT$262.9M
Industry P/E38.8

Technical Analysis

TrendBullish
RSI42.6
SupportNT$54.80
ResistanceNT$73.00
MA 20NT$62.70
MA 50NT$61.21
MA 200NT$60.98
MACDBearish
VolumeDecreasing
Fear & Greed Index90.29

Valuation

Fair ValueNT$33.24
Target PriceNT$67.25
Upside/Downside15.95%
GradeOvervalued
TypeValue

Risk Assessment

Beta0.36
Volatility50.95%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.